Dr. Ball is on Doximity
As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
NIH Clinical Center
10 Center Dr
Bethesda, MD 20892Phone(240) 858-3700
- Is this information wrong?
Summary
- Dr. Mark Ball is a board-certified urologist in Bethesda, MD and is affiliated with National Institutes of Health Clinical Center. He received his medical degree from Johns Hopkins University School of Medicine and has been in practice 7 years. He specializes in minimally invasive surgery and surgical oncology and is experienced in renal cell carcinoma, prostate cancer, pelvic reconstructive surgery, and cystectomy.
Education & Training
- National Cancer InstituteFellowship, Urologic Oncology, 2016 - 2018
Johns Hopkins UniversityResidency, Urology, 2011 - 2016
Johns Hopkins UniversityInternship, General Surgery, 2010 - 2011
Johns Hopkins University School of MedicineClass of 2010
Certifications & Licensure
DC State Medical License 2017 - 2018
MD State Medical License 2013 - 2022- American Board of Urology Urology
Awards, Honors, & Recognition
- Resident Teaching Award Department of Urology, Johns Hopkins University, 2016
- Alpha Omega Alpha Medical Honor Society 2015
- Member Alpha Omega Alpha, 2014
- Join now to see all
Clinical Trials
- Study of 99mTc-Sestamibi SPECT/CT Imaging for the Preoperative Diagnosis of Renal Oncocytoma Start of enrollment: 2014 May 01Gorin, M.A.
- Robot-Assisted MRI-Guided Prostate Biopsy Start of enrollment: 2012 Aug 01Mohamad E Allaf, MD
- A Phase II Study of Bevacizumab and Erlotinib in Subjects With Advanced Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) or Sporadic Papillary Renal Cell Cancer Start of enrollment: 2010 May 04Ramaprasad Srinivasan, M.D.
- The Delayed Intervention and Surveillance for Small Renal Masses (DISSRM) Registry Start of enrollment: 2009 Jan 01Mohamad E Allaf, MD, MBA and Phillip M Pierorazio, MD
- PT2385 for the Treatment of Von Hippel-Lindau Disease-Associated Clear Cell Renal Cell Carcinoma
Publications & Presentations
PubMed
- EDITORIAL COMMENT.Yerram NK, Ball MW> ;Urology.
- EDITORIAL COMMENT.Telfer SI, Ball MW> ;Urology.
- Long term outcomes for patients with von Hippel-Lindau and Pheochromocytoma: defining the role of active surveillanceThomas Sanford, Patrick T. Gomella, Rashid Siddiqui, Daniel Su, Julie Y. An, Gennady Bratslavsky, Mark W. Ball, W. Marston Linehan, Adam R. Metwalli> ;Urologic Oncology-seminars and Original Investigations. 2020 Dec 8
- Join now to see all
Press Mentions
Sierra's ComebackAugust 15, 2020 15:07
AUA 2018: Kidney Cancer Tumor BoardMay 21, 2018 18:00- Partial Versus Radical Nephrectomy for T1-T2 Renal Masses in the Elderly: Comparison of Complications, Renal Function, and Oncologic Outcomes- Beyond the AbstractFebruary 03, 2018 11:00
- Join now to see all
Grant Support
- Clinical Research GrantIntuitive Surgery2013–2014
- GrantSexual Medicine Society of North America2010–2012
Research History
- Fellow, Urologic OncologyLaboratory of W. Marson Linehan, MD. Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute2016 - 2018
- Research FellowJames Buchanan Brady Urological Institute2013 - 2014
Professional Memberships
- Member
- Member
- sexual medicine society of north americaMember
- Member
- Member
- Member
- Society of Urologic Oncology - SUOMember
Hospital Affiliations
- National Institutes of Health Clinical CenterBethesda, Maryland
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
